Press releases
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
More ▼
Key statistics
On Friday, Dexcom Inc (DXCM*:MEX) closed at 2,200.00, -5.13% below its 52-week high of 2,318.97, set on Jul 17, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2,200.00 |
---|---|
High | 2,200.00 |
Low | 2,200.00 |
Bid | 2,091.01 |
Offer | 2,170.41 |
Previous close | 2,200.00 |
Average volume | -- |
---|---|
Shares outstanding | 397.68m |
Free float | 396.24m |
P/E (TTM) | 85.49 |
Market cap | 51.58bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 20 minutes, as of Apr 26 2024 20:59 BST.
More ▼